Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assess the Performance of Spartan COVID-19 V2 System in a Clinical Setting in Comparison to a Laboratory (Standard of Care (SOC)) PCR Method (Canada Alternate)

NCT04628208 is registered in ClinicalTrials.gov with Spartan Bioscience Inc. as lead sponsor.

NCT NCT04628208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04628208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assess the Performance of Spartan COVID-19 V2 System in a Clinical Setting in Comparison to a Laboratory (Standard of Care (SOC)) PCR Method (Canada Alternate)
Lead sponsor
Spartan Bioscience Inc.
Phase
Observational
Overall status
Completed
Start date
November 17, 2020
Completion date
December 7, 2020
Enrollment
81 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19